Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2901
First Guaranty Bancshares
FGBI
$138M
| $472K | ﹤0.01% |
42,424
-44
| -0.1% | -$513 |
2017 Q2
12 quarters
|
|
2902
Grid Dynamics Holdings
GDYN
$645M
| $471K | ﹤0.01% |
+68,200
| New | +$559K |
2020 Q2
0 quarters
|
|
2903
iShares MSCI Intl Quality Factor ETF
IQLT
$13.7B
| $471K | ﹤0.01% |
+16,000
| New | +$447K |
2020 Q2
0 quarters
|
|
|
GLOP
2904
DELISTED
GASLOG PARTNERS LP
GLOP
| $470K | ﹤0.01% |
114,711
-330,700
| -74% | -$1.44M |
2017 Q3
11 quarters
|
|
|
SIC
2905
DELISTED
Select Interior Concepts, Inc. Class A Common Stock
SIC
| $469K | ﹤0.01% |
134,000
-2,100
| -2% | -$6.14K |
2020 Q1
1 quarter
|
|
|
STRS
2906
DELISTED
STRATUS PPTYS INC
STRS
| $468K | ﹤0.01% |
23,600
-12,000
| -34% | -$204K |
2013 Q4
26 quarters
|
|
|
MITO
2907
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
| $468K | ﹤0.01% |
255,557
+127,757
| +100% | +$233K |
2020 Q1
1 quarter
|
|
|
FNJN
2908
DELISTED
Finjan Holdings, Inc.
FNJN
| $467K | ﹤0.01% |
+303,492
| New | +$401K |
2020 Q2
0 quarters
|
|
2909
State Street SPDR Portfolio TIPS ETF
SPIP
$1.01B
| $464K | ﹤0.01% |
+15,400
| New | +$458K |
2020 Q2
0 quarters
|
|
2910
Theriva Biologics
TOVX
$9.96M
| $455K | ﹤0.01% |
3,558
+803
| +29% | +$76.5K |
2018 Q3
7 quarters
|
|
|
STRM
2911
DELISTED
Streamline Health Solutions
STRM
| $454K | ﹤0.01% |
22,746
+66
| +0.3% | +$979 |
2015 Q2
20 quarters
|
|
|
GRCE
2912
Grace Therapeutics
GRCE
$43.8M
| $452K | ﹤0.01% |
20,054
+17,361
| +645% | +$506K |
2019 Q3
3 quarters
|
|
2913
Genpact
G
$5.75B
| $449K | ﹤0.01% |
12,300
-439,500
| -97% | -$14.9M |
2019 Q2
4 quarters
|
|
|
SIFY
2914
Sify Technologies
SIFY
$931M
| $447K | ﹤0.01% |
95,728
+5,173
| +6% | +$27.4K |
2014 Q4
22 quarters
|
|
|
CFB
2915
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $446K | ﹤0.01% |
45,608
+7,500
| +20% | +$68.6K |
2020 Q1
1 quarter
|
|
2916
Better Online Solutions
BOSC
$32.2M
| $445K | ﹤0.01% |
153,043
+10,428
| +7% | +$21.7K |
2017 Q4
10 quarters
|
|
|
STR
2917
DELISTED
Sitio Royalties
STR
| $442K | ﹤0.01% |
34,500
+26,725
| +344% | +$281K |
2020 Q1
1 quarter
|
|
2918
Highway Holdings
HIHO
$3.98M
| $439K | ﹤0.01% |
197,627
+900
| +0.5% | +$1.87K |
2013 Q2
28 quarters
|
|
2919
ProShares UltraPro QQQ
TQQQ
$39.5B
| $439K | ﹤0.01% |
36,000
-29,856
| -45% | -$280K |
2020 Q1
1 quarter
|
|
2920
Performance Shipping
PSHG
$20.6M
| $437K | ﹤0.01% |
4,864
+609
| +14% | +$60.5K |
2019 Q2
4 quarters
|
|
2921
Biglari Holdings Class B
BH
$1.16B
| $434K | ﹤0.01% |
6,295
-9,711
| -61% | -$625K |
2018 Q3
7 quarters
|
|
2922
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$358M
| $434K | ﹤0.01% |
+27,300
| New | +$437K |
2020 Q2
0 quarters
|
|
|
FGC
2923
FG Communities Holdings Inc. Common Stock
FGC
$31.6M
| $428K | ﹤0.01% |
768
+32
| +4% | +$18.6K |
2015 Q3
19 quarters
|
|
2924
Lineage Cell Therapeutics
LCTX
$251M
| $428K | ﹤0.01% |
491,700
+223,300
| +83% | +$197K |
2020 Q1
1 quarter
|
|
|
GSV
2925
DELISTED
Gold Standard Ventures Corp.
GSV
| $428K | ﹤0.01% |
+527,226
| New | +$348K |
2020 Q2
0 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.